KALA BIO, INC. Increase (Decrease) in Other Noncurrent Assets
KALA BIO, INC. (KALA) reported Increase (Decrease) in Other Noncurrent Assets of -$144.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-19
- KALA BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $0.00.
- KALA BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $7.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2023-12-31 was $1.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2023-09-30 was -$1.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$144.00K.
- KALA BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $144.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$144.00K 10-K · filed 2026-04-15 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $7.00K 10-Q · filed 2026-08-19 | ||
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-15 | |||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $144.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $143.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $144.00K 10-Q · filed 2024-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |